BioPharma Credit plc

(the "Company")

NOTICE OF ANNUAL GENERAL MEETING

Following the publication on 16 March 2021 of its Annual Financial Report for the year ended 31 December 2020, the Company announces that it will hold its Annual General Meeting ("AGM") at 1.00 p.m. on 17 June 2021 at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG. 

Given the risks posed by the Covid-19 pandemic, if government guidance at the time of the AGM continues to preclude gatherings of more than a very limited number, the Company will in all likelihood have to impose entry restrictions on shareholder attendance at the AGM. In light of this, the Board strongly recommends all Shareholders to vote on the resolutions to be proposed at the AGM in advance by form of proxy and encourages Shareholders to consider whether, given the circumstances, it is necessary for them to physically attend the Meeting in person. If you appoint the Chairman of the meeting as your proxy, this will ensure your votes are cast in accordance with your wishes without you having to attend the meeting in person.

The Board recognises that the AGM provides an important opportunity to engage with Shareholders and that, notwithstanding the ongoing Covid-19 pandemic, it is important to maintain that. Therefore any Shareholders who wish to ask questions may do so by contacting the Company Secretary at biopharmacreditplc@linkgroup.co.uk. These questions will be answered on a conference call on 11 June 2021 at 2.00 p.m. Shareholders who wish to make use of this facility may do so by contacting Biopharmacredit@buchanan.uk.com.

A copy of the Notice of the AGM is available to view on the Company's website at http://www.bpcruk.com. It has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Notice of the AGM are being posted or made available to the Company's Shareholders today.

Enquiries

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 500

Buchanan

+44 (0)20 7466 5000 / biopharmacredit@buchanan.uk.com

David Rydell

Mark Court

Jamie Hooper

Henry Wilson

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24